NCT07065734 NEgative prEssure Wound Therapy in Renal Transplant
| NCT ID | NCT07065734 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Centro Hospitalar De São João, E.P.E. |
| Condition | Transplant Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 150 participants in total. It began in 2023-01-01 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective study involving patients undergoing open renal transplant. Renal transplant recipients were randomly divided into two groups: the NPWT group, which received NPWT, and the Standard group, which received standard wound dressings.
Eligibility Criteria
Inclusion Criteria: * All patients submitted to kidney transplant Exclusion Criteria: * Pediatric patients, those requiring surgical reinterventions within the first 90 days postoperative, patients allergic to NPWT components, orthotopic transplant
Contact & Investigator
João Alturas Silva, PhD
STUDY DIRECTOR
São João University Hospital
Frequently Asked Questions
Who can join the NCT07065734 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Transplant Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07065734 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07065734 currently recruiting?
Yes, NCT07065734 is actively recruiting participants. Contact the research team at u016845@chsj.min-saude.pt for enrollment information.
Where is the NCT07065734 trial being conducted?
This trial is being conducted at Porto, Portugal.
Who is sponsoring the NCT07065734 clinical trial?
NCT07065734 is sponsored by Centro Hospitalar De São João, E.P.E.. The principal investigator is João Alturas Silva, PhD at São João University Hospital. The trial plans to enroll 150 participants.